India, Aug. 18 -- As India sets an ambitious roadmap to reach a $130 billion pharmaceutical market valuation by 2030, industry leaders converged in Hyderabad to outline the country's shift from volume-driven manufacturing to high-value innovation, research, and global regulatory excellence.

Ahead of the 19th edition of CPHI & PMEC India 2026, scheduled for November across two venues, senior stakeholders emphasized that the next phase of Indian pharma requires a synchronised effort across CDMO services, digital transformation, and stringent quality compliance.

The official launch and precursor event of CPHI & PMEC India 2026, held under the banner of the Pharma Leadership Exchange at the Novotel Hyderabad Convention Centre, brought toget...